(C) 2011 American Institute of Physics. [doi:10.1063/1.3574657]“
“Increasing numbers of patients with non-alcoholic steatohepatitis (NASH) are referred for liver transplant (LT). Our objective was to characterize patients with NASH among referred LT candidates (from 1998 to 2008), and we compared demographics, etiology of liver disease, diabetes, hypertension, smoking, obesity, cardiac disease, cancer, laboratory data, model for end-stage liver disease (MELD), and outcomes between NASH and non-NASH patients. Patients with NASH (n = 71) were compared to other chronic liver disease (n = 472). Patients with NASH were older (58.7 vs. 52.5 yr, p < 0.0001), Asian (53.5% vs. 34.7%, p = 0.03)
and women (50.7% vs. 32.1%, p = 0.003). Patients with NASH had more diabetes, hypertension, obesity, cardiac disease, and smoking history (p < 0.05). Patients with NASH were equally likely to have liver cancer, but more likely to have www.selleckchem.com/products/pd-1-pd-l1-inhibitor-3.html non-liver cancers (20.8% vs. 4.4%, p = 0.008). There was no difference in MELD, but patients with NASH had lower protime/international normalized ratio (1.14 vs. 1.27, p = 0.04) and higher creatinine (1.26 vs. 0.98 mg/dL, p = 0.0018). Patients with NASH were equally likely to undergo evaluation, listing, and transplantation compared to non-NASH patients. While all patients with chronic liver disease can have renal dysfunction because of hepatorenal syndrome, patients with NASH have more
renal dysfunction, perhaps related Rabusertib to diabetes, hypertension, and cardiovascular disease. Transplant centers should consider this carefully in selection of candidates for LT.”
“We present a patient who received
a first-generation posterior chamber phakic intraocular lens (PC pIOL) (Fyodorov IOL) to correct myopia 18 years previously After a long lapse in the follow-up, the patient presented with a reduced endothelial cell count. Although the cataractogenic effect of first-generation PC pIOLs is well known, no sign of cataract was present. The patient was totally satisfied even after 18 years. To our knowledge, this is the first report of a long follow-up of a patient implanted with a first-generation PC pIOL
Financial Disclosure: No author Panobinostat inhibitor has a financial or proprietary interest in any material or method mentioned.
J Cataract Refract Surg 2010; 36.1602-1604 (C) 2010 ASCRS and ESCRS”
“The nucleation, distribution, composition, and structure of Pd nanocrystals in SiO2 multilayers containing Ge, Si, and Pd are studied using high resolution transmission electron microscopy (HRTEM) and x-ray photoelectron spectroscopy (XPS), before and after heat treatment. The Pd nanocrystals in the as deposited sample (sample ASD) seem to be capped by a layer of PdOx. A 1-2 eV shift in binding energy was found for the Pd-3d XPS peak, due to initial state Pd to O charge transfer in this layer. The heat treatment results in a decomposition of PdO and Pd into pure Pd nanocrystals and SiOx. (C) 2011 American Institute of Physics. [doi:10.1063/1.